|
Rates of Mantle Cell Lymphoma are Steadily Rising
Mercredi 09 Juillet 2008 - 14:57 - 4 mois, 2 semaines depuis - 12 lectures - Presse spécialisée - Medscape hematology oncology The incidence of mantle cell lymphoma increased between 1992 and 2004, with a significantly higher incidence in men, white Americans, and people older than 50 years. Most patients were diagnosed with stage 4 disease. Mortality rates also increased during this time period. Medscape Medical News |
|
Cannabis Cigarettes May Reduce Neuropathic Pain
Vendredi 27 Juin 2008 - 09:31 - 4 mois, 3 semaines depuis - 12 lectures - Presse spécialisée - Medscape family medicine Results of a double-blind crossover trial suggest that smoked cannabis relieved neuropathic pain and may be an alternative for those who cannot take other analgesics. Medscape Medical News |
|
Circulating Tumor Cells Predict Overall Survival in Prostate Cancer
Lundi 07 Juillet 2008 - 07:57 - 4 mois, 2 semaines depuis - 12 lectures - Presse spécialisée - Medscape hematology oncology Fewer circulating tumor cells were significantly correlated with longer survival in patients with castration-resistant prostate cancer. Medscape Medical News |
|
Highlights of PAS 2008: Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting
Jeudi 26 Juin 2008 - 09:00 - 4 mois, 3 semaines depuis - 12 lectures - Presse spécialisée - Medscape family medicine Amy L. Baxter, MD, reports on the latest on Kawasaki Disease, MRSA, and more from PAS 2008. Medscape Pediatrics |
|
Good and Evil: A Cancer Vaccine from Tobacco Plants [News]
Mardi 22 Juillet 2008 - 12:00 - 4 mois depuis - 12 lectures - Cancer - Scientific American In the first human trial of its kind, a vaccine grown in genetically engineered tobacco plants has proved to be safe, paving the way to one day use it to help combat a potentially fatal form of non-Hodgkin's lymphoma. [More] |
|
Statins and Prostate Cancer Prevention: Where We Are Now, and Future Directions
Mardi 08 Juillet 2008 - 06:51 - 4 mois, 2 semaines depuis - 12 lectures - Presse spécialisée - Medscape hematology oncology Do statins reduce the risk of prostate cancer? Find out how these widely prescribed drugs may be working as double agents. Nature Clinical Practice Urology |
|
Emerging Therapies for Melanoma
Mercredi 09 Juillet 2008 - 08:23 - 4 mois, 2 semaines depuis - 12 lectures - Presse spécialisée - Medscape hematology oncology Treatments for melanoma have evolved to keep pace with improved understanding of cellular activity. This review summarizes what has taken place over the last five years. Expert Review of Anticancer Therapy |
|
Is China's Pollution Poisoning Its Children? [Features]
Lundi 14 Juillet 2008 - 08:00 - 4 mois, 1 semaine depuis - 12 lectures - Cancer - Scientific American Editor's Note: This story will be published in the August issue of Scientific American.A few heaping piles of scrap metal and a rusty coal shed are all that is left of the power plant that until recently squatted like an immense, smoke-belching dragon in the middle of Tongliang, a gray city of 100,000 in south-central China. As we walk toward the shed, a Belgian Shepherd begins barking furiously, jerking its iron chain and baring sharp teeth. A brown-eyed face peeks out from the open doorway--it belongs to a girl in a stained shirt, holding a tabby cat that jumps away to hide under a slab of concrete as we approach. The girl is no more than six or seven years old and appears to be living in the shed with her father, who watches us warily from within. [More] |
|
Un test génétique pour choisir les embryons humains les plus viables
Jeudi 15 Mai 2008 - 06:32 - 6 mois, 1 semaine depuis - 12 lectures - Presse généraliste - Le monde Sciences Une équipe australo-grecque a mis au point une méthode qui pourrait permettre d'améliorer considérablement les taux de succès des fécondations in vitro. |
|
OGM : le Parlement revotera finalement sur le même texte
Mercredi 14 Mai 2008 - 11:42 - 6 mois, 1 semaine depuis - 12 lectures - Presse généraliste - Le monde Sciences Le projet de loi, rejeté mardi à l'Assemblée, a finalement été approuvé par la commission mixte paritaire, mercredi. L'opposition a quitté la réunion, dénonçant "un simulacre de discussion". |
< 1 – 11 – 21 – 31 – 41 – 51 – 61 – 71 – 81 – 91 – 101 – 111 – 112 – 113 – 114 – 115 – 116 – 117 – 118 – 119 – 120 – 121 – 122 – 123 – 124 – 125 – 126 – 127 – 128 – 129 – 130 – 131 – 132 – 133 – 134 – 135 – 136 – 137 – 138 – 139 – 140 – 141 – 151 – 161 – 171 – 181 – 191 – 201 – 211 – 221 – 231 – 241 – 251 – 261 – 271 – 281 – 291 – 301 – 311 – 321 >